Stay updated on Pembrolizumab in Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Breast Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    ClinicalTrials.gov updated the page’s software/version revision marker from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-25T05:28:54.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-18T03:49:08.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Added the condition 'Inflammatory breast carcinoma' and the Genetic and Rare Diseases Information Center as a resources link. Updated revision labels from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-20T02:05:34.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-05T18:38:24.000Z thumbnail image
  7. Check
    89 days ago
    Change Detected
    Summary
    Revision: v3.4.2 replaces v3.4.1 on the page, a minor update with no changes to core study information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T01:41:53.000Z thumbnail image
  8. Check
    96 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:09:28.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Breast Cancer Clinical Trial page.